PubMed COVID-19 Clinical Care

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

Artificial Intelligence in battling infectious diseases: A transformative role

Friday, January 05, 2024 - 4:00 AM

It is widely acknowledged that infectious diseases have wrought immense havoc on human society, being regarded as adversaries from which humanity cannot elude. In recent years, the advancement of Artificial Intelligence (AI) technology has ushered in

Acceptance and User Experiences of a Wearable Device for the Management of Hospitalized Patients in COVID-19-Designated Wards in Ho Chi Minh City, Vietnam: Action Learning Project

Friday, January 05, 2024 - 4:00 AM

CONCLUSIONS: Designing and implementing the devices to be more nurse-centric from their introduction could have helped to increase their efficiency and use during the complex pandemic period.